Severe disease activity in MS patients treated with cladribine after fingolimod withdrawal

Maria Cellerino, Simona Bonavita, Margherita Ferrero, Matilde Inglese, Giacomo Boffa

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Article number117156
JournalJournal of the Neurological Sciences
Publication statusPublished - Nov 15 2020


  • Breakthrough disease activity
  • Cladribine
  • Fingolimod withdrawal
  • Multiple sclerosis

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this